reports
Mandiri Herindo Adiperkasa Tbk PT: 1 director
A director at Mandiri Herindo Adiperkasa Tbk PT bought 20,000,000 shares at 206.000IDR and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
Porr AG: 1 director
A director at Porr AG bought 5,000 shares at 14.295EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Schwab Charles Corp: 6 directors
Six Directors at Schwab Charles Corp sold/gave away/sold after exercising options 101,360 shares at between 0.000USD and 73.460USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tr...
BTS Group Holding PCL: 1 director
A director at BTS Group Holding PCL bought 5,000,000 shares at 6.000THB and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Cloudflare Inc: 2 directors
A director at Cloudflare Inc sold/sold after exercising options 64,100 shares at 89.039USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
- Adam Antoniak
- James Knightley
- Lynn Song
- Min Joo Kang
- Muhammet Mercan
- Nicky Mapa
- Peter Virovacz
- Rob Carnell
Fifth Third Bancorp Reports First Quarter 2024 Diluted Earnings Per Sh...
CINCINNATI--(BUSINESS WIRE)-- Fifth Third Bancorp (NASDAQ: FITB): Key Financial Data Key Highlights $ in millions for all balance sheet and income statement items 1Q24 4Q23 1Q23 Stability: Average deposits increased 5% compared to 1Q23 Net charge-offs, NPAs, and delinquencies r...
Ault Alliance Has Received an Investment of $44 Million to Date from A...
LAS VEGAS--(BUSINESS WIRE)-- (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced Ault & Company, Inc. (“Ault & Company”), an affiliate of the Company, has invested a total of $44.0 million pursuant to the Securities Purchase Agreement (the “Agreement”) entered into between the Company and Ault & Company on November 6, 2023. To date, Ault & Company has purchased an aggregate of 44,000 shares of Series C convertible preferred stock (“Series C Preferred Stock”) and warrants (“Series C Warrants”) to purchase an aggregate of approximately 13.0 ...
Hubspot Inc: 1 director
A director at Hubspot Inc sold after exercising options/sold 8,500 shares at 636.180USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Inspire Medical Systems Inc: 1 director
A director at Inspire Medical Systems Inc sold 15,000 shares at 230.030USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
EQS-News: aconnic AG (vormals UET AG) erzielt starkes Umsatzwachstum i...
EQS-News: UET United Electronic Technology AG / Schlagwort(e): Vorläufiges Ergebnis/Quartalsergebnis aconnic AG (vormals UET AG) erzielt starkes Umsatzwachstum im 4. Quartal und im Gesamtjahr 2023 19.04.2024 / 12:17 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Gesamtumsatz steigt um 48 % auf 72,7 Mio. EUR Vorläufiges operatives Ergebnis vor Zinsen und Steuern (EBIT) legte auf 5,9 Mio. EUR zu Auftragsbestand beläuft sich auf 32,6 Mio. EUR Die aconnic AG (ISIN: DE000A0LBKW6), München, setzt das Wachstum auch im vierten Quartal 2023...
EQS-News: aconnic AG (formerly UET AG) with strong revenue growth in Q...
EQS-News: UET United Electronic Technology AG / Key word(s): Preliminary Results/Quarter Results aconnic AG (formerly UET AG) with strong revenue growth in Q4 2023 and full year 2023 19.04.2024 / 12:17 CET/CEST The issuer is solely responsible for the content of this announcement. Consolidated revenue grows by 48% to 72.7 mn EUR Preliminary operating earnings before interest and taxes (EBIT) increased to 5.9 mn EUR Order backlog amounts to 32.6 mn EUR aconnic AG (ISIN: DE000A0LBKW6), based in Munich, continues its growth in the fourth quarter of 2023. With high demand i...
Moody's Ratings affirms A3 ratings of Anhui Transport; outlook stable
Moody's Ratings (Moody's) has today affirmed Anhui Transportation Holding Group Co., Ltd.'s (Anhui Transport) A3 issuer rating and baa3 Baseline Credit Assessment (BCA). At the same time, Moody's has affirmed Anhui Transportation Holding Group (H.K.) Ltd's A3 backed senior unsecured rating. Moody'...
Alvotech signs U.S. agreement to expand access for newly approved high...
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab) Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira®The agreement broadens patient access and further commitment to availability of vital biologics in the U.S. and globally Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for p...
Alvotech signs U.S. agreement to expand access for newly approved high...
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab) Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira® The agreement broadens patient access and further commitment to availability of vital biologics in the U.S. and globally REYKJAVIK, Iceland, April 19, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the de...
Alvotech gerir sölusamning í Bandaríkjunum um fyrstu líftæknilyfjahlið...
Alvotech gerir sölusamning í Bandaríkjunum um fyrstu líftæknilyfjahliðstæðuna í háum styrk með útskiptanleika við Humira Langtímasamningur hefur náðst við leiðandi innkaupaaðila lyfja í Bandaríkjunum um sölu- og dreifingu á líftæknilyfjahliðstæðu Alvotech í háum styrk með útskiptanleika við HumiraMeð þessum samningi eykst útbreiðsla hliðstæðunnar í Bandaríkjunum og aðgengi sjúklinga að hagkvæmari líftæknilyfjum Alvotech (NASDAQ: ALVO) tilkynnti í dag að félagið hefði gert langtímasamning við leiðandi innkaupaaðila lyfja í Bandaríkjunum um sölu og markaðssetningu á adalimumab-ryvk, fyrst...
Integrated Research Limited: 1 director
A director at Integrated Research Limited bought 260,000 shares at 0.378AUD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.